首页> 外国专利> Process for producing pharmaceutical compositions comprising peptides, vasopeptidase inhibitors, EVASINs, analogs and derivatives thereof secreted from snakes, in particular the venom gland of Jalaraca, and related products and late-stage degenerative diseases for use development Use in

Process for producing pharmaceutical compositions comprising peptides, vasopeptidase inhibitors, EVASINs, analogs and derivatives thereof secreted from snakes, in particular the venom gland of Jalaraca, and related products and late-stage degenerative diseases for use development Use in

机译:用于生产蛇毒,尤其是Jalaraca蛇毒腺分泌的肽,血管肽酶抑制剂,EVASIN,其类似物和衍生物的药物组合物的方法,以及用于开发用途的相关产品和晚期退行性疾病

摘要

The present invention is characterized by the process of preparation of pharmaceutical compositions for the development of applications of the Evasins and their structural and/or conformational analogues in chronic-degenerative diseases. It is further characterized by the process of preparation of pharmaceutical compositions and related products of the Evasins peptides and their structural and/or conformational analogues in using the cyclodextrins, its derivatives, liposomes and biodegradable polymers and/or mixture of these systems. The invention is further characterized by the increased efficacy of these peptides and their analogues included in cyclodextrins, when administered to rats. This characterizes an increased biodisponibility of these peptides and their analogues using the compositions of the present invention.
机译:本发明的特征在于制备药物组合物的方法,该药物组合物用于开发Evasins及其结构和/或构象类似物在慢性变性疾病中的应用。其特征还在于使用环糊精,其衍生物,脂质体和可生物降解的聚合物和/或这些系统的混合物,制备Evasins肽的药物组合物和相关产物及其结构和/或构象类似物的方法。当给予大鼠时,这些肽及其包括在环糊精中的类似物的功效增强,其特征在于本发明。这表征了使用本发明的组合物这些肽及其类似物的生物适应性提高。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号